Teva Sues Mylan, Others Over Proposed Azilect Generic
Teva Pharmaceutical Industries Ltd. filed suit on Tuesday against several generics makers in an attempt to prevent off-label versions of its Parkinson's disease treatment Azilect from hitting drugstore shelves prior to...To view the full article, register now.
Already a subscriber? Click here to view full article